


Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
Double Rainbow Announces Membership with BioMADE

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics

Double Rainbow announces $10 million investment from Betta Pharmaceuticals
